Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience

By Ferrantelli Flavia   Buttò Stefano   Cafaro Aurelio   Wahren Britta   Ensoli Barbara  

Springer Seminars in Immunopathology, Vol. 28, Iss. 3, 2006-11 ,pp. : 289-301

Springer Publishing Company

Access to resources Recommend Favorite

Progress in development and testing of novel recombinant vaccine platforms for HIV

By Weiner David  

Springer Seminars in Immunopathology, Vol. 28, Iss. 3, 2006-11 ,pp. : 195-196

Springer Publishing Company

Access to resources Recommend Favorite

The Tumor Recall Response of Antitumor Immunity Primed by a Live, Recombinant Listeria monocytogenes Vaccine Comprises Multiple Effector Mechanisms

By Weiskirch L.M.   Pan Z-K.   Paterson Y.  

Clinical Immunology, Vol. 98, Iss. 3, 2001-03 ,pp. : 346-357

Academic Press

Access to resources Recommend Favorite

Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials

By Capone Stefania   D'Alise Anna Morena   Ammendola Virginia   Colloca Stefano   Cortese Riccardo   Nicosia Alfredo   Folgori Antonella  

Expert Review of Vaccines, Vol. 12, Iss. 4, 2013-04 ,pp. : 379-393

Informa Healthcare

Access to resources Recommend Favorite

Recombinant BCG Vaccine Candidates

By  

Current Molecular Medicine, Vol. 7, Iss. 4, 2007-06 ,pp. : 365-372

Bentham Science Publishers

Access to resources Recommend Favorite